Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | PSMC3 |
| Upstream (Parents) |
|---|
| (<<) ACTB → PSMC3 |
| (<<) HSP90AB1 → PSMC3 |
| Downstream (Children) |
|---|
| PSMC3 → UBE2M (>>) |
| PSMC3 → CASK (>>) |
| PSMC3 → TOLLIP (>>) |
| PSMC3 → RFC2 (>>) |
| PSMC3 → DCLRE1A (>>) |
| PSMC3 → CCT7 (>>) |
| PSMC3 → NSFL1C (>>) |
| PSMC3 → RHOD (>>) |
| PSMC3 → PGD (>>) |
| PSMC3 → BCL7C (>>) |
| PSMC3 → KDM4C (>>) |
| PSMC3 → SSX5 (>>) |
| PSMC3 → WARS (>>) |
| PSMC3 → RHOC (>>) |
| PSMC3 → YKT6 (>>) |
| PSMC3 → ACTBP9 (>>) |
| PSMC3 → CTSD (>>) |
| PSMC3 → SLC12A5 (>>) |
| PSMC3 → MTMR8 (>>) |
| PSMC3 → MSR1 (>>) |
| PSMC3 → DDX19A///DDX19B (>>) |
| PSMC3 → OTUB1 (>>) |
| PSMC3 → CDKAL1 (>>) |
| PSMC3 → H2AFY (>>) |
| PSMC3 → PRPF31 (>>) |
| PSMC3 → MAD1L1 (>>) |
| PSMC3 → CPT2 (>>) |
| PSMC3 → ABI3BP (>>) |
| PSMC3 → EBP (>>) |
| PSMC3 → ANP32A (>>) |
